The medication helps you reduce appetite, but your habits shape your long-term results
Preliminary real-world data from Milliman suggests that while increased GLP-1 adherence may lower the medical cost of care for certain chronic conditions, these offsets do not yet fully recover the high cost of the medications themselves
They bind to GLP-1 receptors located throughout the body, including the pancreas, brain, gastrointestinal tract, and cardiovascular system
Still, having more options "could indeed impact the prescribing landscape," Dr
Future research should study the effects of lipophilic toxin redistribution caused by GLP-1 agonist drugs, as well as analyze and correlate these to specific mortality and disease metrics
Detailed statistics are in Supplementary Table 1